Holly May Archives - CDR – Chain Drug Review

WBA expands disability representation

November 10, 2022 by Chain Drug Review Holly May, The goal is a core component of the company’s expanded U.S. health equity performance goal, WBA Featured Articles, Leading Headlines, Retail News

DEERFIELD, Ill. — Walgreens Boots Alliance, Inc. (WBA) has announced it is strengthening its commitment to increasing the representation of people with disabilities at all levels across the company’s U.S. segments and redesigning its annual bonus plan in the U.S. to include a disability representation metric to drive this commitment. The company will be the

Walgreens Boots Alliance fills key roles

October 12, 2021 by Chain Drug Review Anita Allemand, Holly May, Roz Brewer, Walgreens Boots Alliance Featured Articles, Leading Headlines, Retail News

DEERFIELD, Ill. — Walgreens Boots Alliance has filled two key executive leadership positions, the company said on Tuesday. Holly May was appointed executive vice president and global chief human resources officer and Anita Allemand was appointed chief transformation and integration officer. May and Allemand will both report to WBA CEO Roz Brewer, as members of